seekingalpha.com
/3 weeks ago
Latest updates for Vktx
Fresh curated links around VKTX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Viking Therapeutics, Inc. (VKTX) Q2 2026 Earnings Call Transcript
- Is This Biotech Stock a Buy After Its Massive Rally?
- This GLP-1 Stock Could Double by 2030. Here's Why
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
fool.com
/1 month ago
Is This Biotech Stock a Buy After Its Massive Rally?
This biotech has a powerful growth story, but one competitive threat could reshape the entire investment case before the payoff arrives.
fool.com
/1 month ago
This GLP-1 Stock Could Double by 2030. Here's Why
Investors need to ask tough questions before initiating a position in this biotech company.
seekingalpha.com
/1 month ago
Corporación Inmobiliaria Vesta, S.A.B. de C.V. (VTMX) Q2 2026 Earnings Call Transcript
fool.com
/1 month ago
Here's Why Viking Therapeutics Stock Surged Higher in June
Investors are growing more optimistic over the company's pipeline and the initiation of a Phase 1 trial with a new drug.
seekingalpha.com
/2 weeks ago
Vertex Pharmaceuticals Incorporated (VRTX) Q2 2026 Earnings Call Transcript
seekingalpha.com
/2 weeks ago
Vertex Pharmaceuticals Incorporated 2026 Q2 - Results - Earnings Call Presentation
fool.com
/1 month ago
Is Viking Therapeutics Stock Going to $100?
That would be an impressive run if it could get there soon.
seekingalpha.com
/3 weeks ago
Develop Global Limited (VTEXF) Q4 2026 Earnings Call Transcript
fool.com
/1 month ago
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics Just Started Testing a Weight Loss Drug That Goes Beyond GLP-...
Viking's latest program seeks to push the envelope in weight loss efficacy.
seekingalpha.com
/1 month ago
Travere Therapeutics: Filspari Is Becoming A Rare Kidney Disease Platform
oilandgas360.com
/1 month ago
Vitol weighs $2.3-billion sale of Delaware basin producer VTX Energy
(World Oil) – Vitol Group is in late stage talks to sell its shale oil venture VTX Energy Partners LLC to a consortium of […]
fool.com
/1 month ago
Vertex Pharmaceuticals Stock Is Soaring and at a New All-Time High. Could It Still Be Heading Even Higher?
The pharma stock is up around 17% this year.
fool.com
/1 month ago
Kestra Medical (KMTS) Q4 2026 Earnings Call Transcript
Revenue surged 66% in Q4 as prescriptions climbed 63% year over year.
finance.yahoo.com
/1 month ago
Is Edgewise Therapeutics, Inc. (EWTX) A Good Stock To Buy Now?
fool.com
/1 month ago
Is This Biotech Stock a Buy Near Its 52-Week High?
It's been a volatile year for the company, but don't let that scare you away.
seekingalpha.com
/1 month ago
MarketAxess: A High-ROIC Company Trading At An Attractive Valuation
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Vktx
seekingalpha.com
Recent coverage from public sources
Public source
oilandgas360.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source